Dataset from An Open Label Phase 3 Trial to Evaluate the Safety of ALD403 Administered Intravenously in Patients With Chronic Migraines
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00008256
下载链接
链接失效反馈官方服务：
资源简介：
An evaluation of long term safety of repeat ALD403 doses in Chronic Migraine
创建时间：
2024-11-26
